I remember a lot more than that. I also remember you telling us that the lack of control group, and the low RPE of the Kenyans was "disappointing". I think we are both in agreement here.
For everyone else, in this Kenyan study, these almost elite Kenyans, if properly trained for the distance, were likely capable of low-8:00's for 3000m. They participated in a study, essentially treating the time trials like a tempo runs, as indicated by the measured RPE, running around 9:05 pre-EPO, and improving to around 8:40, post-EPO.
Alexa Efraimson and Mary Cain ran similar times in high school.
I guess by "microdose. Cute" -- you mean the OP, and the subject line, and not me or any of my posts. As we have seen from the CIRC report, the consensus among cyclists is that the lower doses post-ABP led to significantly lower expected improvements, in cycling, giving clean riders hope, and a choice to reject doping.
casual obsever wrote:
And yet, I am sure you remember the study on (almost by your standards) elite Kenyan runners, who improved in a time trial by 5% after moderate EPO dosages for a few weeks, which would not have have triggered the ABP either, thanks to its ludicrously high thresholds.
Of course they would have to watch out during their glowing times, e.g. by installing a quiet doorbell just in case.
There the blood transfusions are easier. As I pointed out here repeatedly, one can safely use 200 ml bags, and no alarms will ever go off. Simple math, and the athletes know it.
What' funny though is that half a regular blood bag is now called a microdose. Cute.